Arovella Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$5.12M $8.17M $6.98M $9.58M $0.33M $0.04M $4.00M $3.12M $4.00M $4.07M $8.75M $5.86M $5.86M $0.55M $0.49M $1.25M $1.25M $0.99M $0.30M $1.45M $0.00M
GM % Gross Margin %
47.01% 37.01% 42.74% 30.16% -58.49% -56.69% 21.03% 18.57% 14.99% 19.80% 30.17% 14.26% 13.92% 89.73% 47.41% 82.04% 82.05% 75.29% 30.00% 86.01% 0.00%
OM Operating Margin
-14.96% -18.49% -20.23% -25.49% 0.00% 0.00% -61.13% -92.22% -48.90% -43.74% -21.64% -65.66% -49.98% 0.00% 0.00% -187.80% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$-0.03 $-0.01 $-0.01 $-0.01 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.00% -0.00% -0.00% 0 0
Sha. Shares
0m 4.85m 5.13m 6.32m 6.86m 7.97m 14.22m 18.13m 23.78m 24.34m 36.76m 39.36m 45.62m 45.69m 48.86m 103.28m 142.25m 383.54m 480.92m 669.92m 923.9m
OCF Operating Cash Flow
$-0.94M $-0.68M $-0.54M $-2.20M $-2.70M $-1.68M $-2.36M $-3.19M $-1.77M $-1.61M $-2.61M $-3.15M $-1.80M $-0.85M $-2.55M $-2.50M $-2.88M $-3.54M $-6.27M $-6.40M $0.00M
FCF Free Cash Flow
$-1.36M $-1.08M $-0.89M $-2.35M $-2.90M $-1.71M $-2.39M $-3.23M $-1.79M $-1.69M $-2.90M $-3.43M $-1.87M $-0.93M $-2.62M $-2.81M $-3.02M $-3.71M $-6.31M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$-0.39 $-0.22 $-0.17 $-0.40 $-0.42 $-0.22 $-0.17 $-0.17 $-0.08 $-0.10 $-0.14 $-0.11 $-0.07 $-0.05 $-0.07 $-0.04 $-0.02 $-0.01 $-0.01 $-0.01 $0.00